Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00619515 · ClinicalTrials.gov registry record · NA
Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer
A NA study, sponsored by Case Comprehensive Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT00619515 is a NA study that was terminated before completion, run by Case Comprehensive Cancer Center. The registered enrollment target is 73 participants.
The verdict
NCT00619515, a NA study, was terminated before completion, sponsored by Case Comprehensive Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This trial is studying the side effects of stereotactic radiation therapy and to see how well it works in treating patients with prostate cancer.
Interventions
- OTHER questionnaire administration
- RADIATION stereotactic radiosurgery
- PROCEDURE implanted fiducial-based imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-12 |
| Est. Completion | 2013-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00619515
The ClinicalTrials.gov registry entry for NCT00619515 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which questionnaire administration is the first listed.
NCT00619515 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00619515 about?
NCT00619515 is a clinical study titled "Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer". RATIONALE: Stereotactic radiation therapy may be able to send x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: This trial is studying the side effects of stereotactic radiation therapy and to see how well it works in treating patients with prostate cancer.
What is the current status of trial NCT00619515?
This trial is currently terminated. It is a NA study. The enrollment target is 73 participants. The study started on 2007-12. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00619515?
The interventions under investigation include: questionnaire administration (OTHER), stereotactic radiosurgery (RADIATION), implanted fiducial-based imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00619515?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.